Excerpt

In October 1999, the Forum on Emerging Infections of the Institute of Medicine convened a 2-day workshop titled “International Aspects of Emerging Infections.” Key representatives from the international community explored the forces that drive emerging infectious diseases to prominence. Representatives from the Americas, Africa, Asia and the Pacific, and Europe made formal presentations and engaged in panel discussions. Summaries of the formal presentations can be found in Chapter 1, Chapter 2, Chapter 3, Chapter 4 through Chapter 5 of this report. The topics addressed during this conference cover a wide range of issues, including trends in the incidence of infectious diseases around the world, descriptions of the wide variety of factors that contribute to the emergence and reemergence of these diseases, efforts to coordinate surveillance activities and responses within and across borders, and the resource, research, and international needs that remain to be addressed.

Contents

• THE NATIONAL ACADEMIES
• FORUM ON EMERGING INFECTIONS
• REVIEWERS
• Preface
• Summary and Assessment
  Joshua Lederberg, Ph.D.
  • EMERGING INFECTIONS: THE GLOBAL PICTURE
  • FACTORS IN EMERGENCE OF INFECTIOUS DISEASES
  • NEED FOR COORDINATION AND COLLABORATION
  • NETWORKS OF GLOBAL SURVEILLANCE
  • TAKING ADVANTAGE OF WINDOWS OF OPPORTUNITY
• 1. Introduction
  David Heymann, M.D., M.T.M.
  • LOST WINDOWS OF OPPORTUNITY
  • GLOBAL RESPONSES TO EMERGING INFECTIONS
  • WINDOWS OF OPPORTUNITY FOR THE FUTURE
• 2. Emerging Infections in Latin America
  • OVERVIEW
  • EMERGING INFECTIONS IN COLOMBIA: A NATIONAL PERSPECTIVE
  • A NATIONAL STRATEGY FOR EMERGING INFECTIOUS DISEASES: THE ARGENTINE CASE OF 1999
  • DIAGNOSIS, EPIDEMIOLOGICAL SURVEILLANCE, AND CONTROL PROGRAMS FOR EMERGING AND RE-EMERGING INFECTIOUS DISEASES IN MEXICO
  • RESPONSE OF THE PAN AMERICAN HEALTH ORGANIZATION TO COMBATING EMERGING INFECTIOUS DISEASES IN LATIN AMERICA AND THE CARIBBEAN
• 3. Emerging Infections in Africa
  • OVERVIEW
  • INTEGRATED DISEASE SURVEILLANCE AND EPIDEMICS: PREPAREDNESS AND RESPONSE IN AFRICA
  • GLOBAL EMERGING INFECTIOUS DISEASES
  • EMERGING INFECTIONS IN AFRICA: THE WHO RESPONSE
• 4. Emerging Infections in Asia and the Pacific Region
  • OVERVIEW
  • EMERGING INFECTIOUS DISEASES IN HONG KONG AND THEIR PUBLIC HEALTH SIGNIFICANCE
  • EMERGING DISEASES IN THE AUSTRALASIAN REGION
  • INTERNATIONAL SMART PARTNERSHIP IN EMERGING DISEASES: SENSE AND SENSITIVITY
• 5. Emerging Infections in Europe
  • OVERVIEW
  • PANDEMIC STRATEGIC PLANNING
  • A VIEW FROM THE GROUND: TUBERCULOSIS AS AN EXAMPLE OF A REEMERGING INFECTIOUS DISEASE IN THE FORMER SOVIET UNION
  • EUROPEAN RESPONSES TO EMERGING INFECTIONS AND THEIR POLICY IMPLICATIONS
• References
• APPENDIXES
  • APPENDIX A Glossary and Acronyms
  • APPENDIX B Workshop Agenda
  • APPENDIX C Workshop Participants
  • APPENDIX D Forum Member and Staff Biographies

This report is based on the proceedings of a workshop that was sponsored by the Forum on Emerging Infections. It is prepared in the form of a workshop summary by and in the name of the editors, with the assistance of staff and consultants, as an individually authored document. Sections of the workshop summary not specifically attributed to an individual reflect the views of the editors and not those of the Forum on Emerging Infections. The content of those sections is based on the presentations and the discussions that took place during the workshop.

Support for this project was provided by the U.S. Department of Health and Human Services’ National Institutes of Health, Centers for Disease Control and Prevention, and U.S. Food and Drug Administration; U.S. Department of Defense; U.S. Department of State; U.S. Department of Veterans Affairs; Abbott Laboratories; American Society for Microbiology; Bristol-Myers Squibb Company; Burroughs Wellcome Fund; Eli Lilly & Company; Glaxo Wellcome; F. Hoffmann-La Roche, AG; Pfizer, Inc.; SmithKline Beecham Corporation; and Wyeth-Ayerst Laboratories.

The views presented are those of the editors and workshop participants and are not necessarily those of the funding organizations.

NOTICE: The project that is the subject of this workshop summary was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.